Attelind, Sofia
Eriksson, Niclas
Wadelius, Mia
Hallberg, Pär
Article History
Received: 28 May 2025
Accepted: 3 June 2025
First Online: 16 June 2025
Declarations
:
: SA is employed by the Swedish Medical Products Agency, SE-751 03 Uppsala, Sweden. The views expressed in this paper are the personal views of the authors and not necessarily the views of the Government agency. NE reports institutional research grant from Bristol-Myers Squibb/Pfizer. MW and PH declare that they have no conflict of interest.
Free to read: This content has been made available to all.